The Dow industrials, Nasdaq Composite and S&P 500 all fell some 1% Tuesday as markets awaited Wednesday’s Federal Reserve interest-rate decision and brushed off the latest news in U.S. President Donald Trump’s tariff battles. The$Dow Jones Industrial Average (.DJI.US)$led the way downward in percentage terms, shedding 389.83 points (0.95%) to a 40,829 close. The$Nasdaq Composite Index (.IXIC.US)$followed with a 154.58-poin...
What happened: In recent weeks,$Janux Therapeutics (JANX.US)$has seen significant insider buying, notably from RA Capital Management, which acquired shares worth approximately $25.3M. Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges. Key Developments: 📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...
After pulling back during the day, the S&P 500 and Nasdaq hit fresh closing highs- and the Nasdaq hit a trading high of 19,486.15. Just past 4 pm ET the$S&P 500 Index (.SPX.US)$climbed 0.05%, the$Dow Jones Industrial Average (.DJI.US)$fell 0.17%, and the$Nasdaq Composite Index (.IXIC.US)$climbed 0.40%. MACRO JOLTS job openings from the Bureau of Labor Statistics came in at 7.74M, higher than last month's number, but ever since Ap...
As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year. Janux Therapeutics Inc. (NASDAQ: JANX) Janux Therapeutics is a clinical-stage bioph...
Coyliss Fountano
:
I’m up in LB (on another platform) 109%. Took a chance right after it IPO’d. First really good move I made as I am new to personal investing!
Hey everyone! Like I mentioned in the last post, the big news is that MoomooCA has set up a server for me, and it's open for all of you to join! It’s called Trader’s Tavern, and yes—the profile pic is my cat <3 In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there! In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim f...
11
2
Report
Smangler
:
Send a link to the tavern I want to join
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Janux Therapeutics Stock Forum
The $Dow Jones Industrial Average (.DJI.US)$ led the way downward in percentage terms, shedding 389.83 points (0.95%) to a 40,829 close. The $Nasdaq Composite Index (.IXIC.US)$ followed with a 154.58-poin...
Promising 7.5 Month PFS: JANX007 Expands to Earlier-Stage Prostate Cancer Treatment in Phase 1b Trial
Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges.
Key Developments:
📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.05%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.17%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.40%.
MACRO
JOLTS job openings from the Bureau of Labor Statistics came in at 7.74M, higher than last month's number, but ever since Ap...
📊⚡️📊
Janux Therapeutics Inc. (NASDAQ: JANX)
Janux Therapeutics is a clinical-stage bioph...
In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there!
In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim f...
$Merck & Co (MRK.US)$ already has an active partnership with $Janux Therapeutics (JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF (XBI.US)$ in which $Merck & Co (MRK.US)$ already has a seat at the table.
$Merck & Co (MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engag...
No comment yet